跳至主要内容
临床试验/ISRCTN61391164
ISRCTN61391164已完成未知

A randomized controlled trial of Concurrent treatment of PTSD and Substance Use Disorders using Prolonged Exposure (COPE) and Relapse Prevention (RP) in women with PTSD and Alcohol Use Disorder.

Rosenlunds sjukhus [Rosenlund Hospital]0 个研究点目标入组 90 人开始时间: 2019年3月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 2. Aged 18 years or older
  • 3. Current PTSD and moderate to severe AUD, according to DSM-5 and clinical assessment

排除标准

  • 1. Current moderate to severe SUD, other than alcohol and nicotine, according to DSM-5
  • 2. Current or not stably treated psychosis
  • 3. Suicidal or homicidal ideation deemed to be in need of treatment before study treatment can start
  • 4. Current medication, which may affect the study outcome, and which is deemed impossible to discontinue for the duration of the study, primarily AUD medication
  • 5. Insufficient memory of the trauma (assessed using the CAPS-5)
  • 6. Dissociation which is more difficult or affects the subject more than her PTSD
  • 7. Somatic or psychiatric illness where it is deemed to not be in the subject’s best interest to participate in the study
  • 8. IQ < 70

研究者

发起方
Rosenlunds sjukhus [Rosenlund Hospital]

相似试验